Cargando…
Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
PURPOSE: Efficacy, tolerability and safety of the novel preservative-free prostaglandin tafluprost 0.0015% were investigated for the treatment of patients with glaucoma or ocular hypertension in a clinical setting. PATIENTS AND METHODS: Data were collected in a non-interventional, prospective, multi...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104790/ https://www.ncbi.nlm.nih.gov/pubmed/21629567 http://dx.doi.org/10.2147/OPTH.S17876 |